Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind, placebo-controlled Phase 2 study of CAT-354 in uncontrolled asthma
2007-002090-31Phase 2Terminated
- Sponsor
- MedImmune
- Start
- Aug 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing CAT-354 with Placebo (2 arms). Primary endpoint: Change in methacholine doubling concentration. Started Aug 2007; status: terminated.
02
Drugs
tralokinumab
03
Conditions
asthma
Beyond the preview
Go deeper on 2007-002090-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002090-31.